PHG
Koninklijke Philips N.V. NYSE Listed Mar 17, 1980$26.78
+2.06%
vs $26.24
Mkt Cap $25.8B
52w Low $22.06
43.5% of range
52w High $32.91
50d MA $26.90
200d MA $27.99
P/E (TTM)
28.8x
EV/EBITDA
11.3x
P/B
2.4x
Debt/Equity
0.7x
ROE
—
P/FCF
28.9x
RSI (14)
53.30
ATR (14)
$0.48
Beta
0.96
50d MA
$26.90
200d MA
$27.99
Avg Volume
1.2M
Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Philips Center · Amsterdam 1096 BC · NL
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | BMO | 0.56 | 0.70 | +23.9% | 32.91 | -3.3% | -2.6% | -2.1% | -0.5% | -0.1% | +0.8% | — |
| Nov 4, 2025 | BMO | 0.37 | 0.37 | +0.0% | 28.02 | +0.8% | +0.2% | +0.6% | -0.2% | +0.3% | +3.8% | — |
| Jul 29, 2025 | BMO | 0.32 | 0.41 | +29.2% | 28.02 | -1.9% | -4.3% | -2.3% | +1.0% | +1.0% | -1.3% | — |
| May 6, 2025 | BMO | 0.14 | 0.27 | +92.9% | 24.09 | +0.9% | -0.8% | +0.8% | +2.0% | +2.0% | -3.3% | — |
| Feb 19, 2025 | BMO | 0.55 | 0.54 | -1.8% | 25.05 | +0.8% | -0.1% | +2.1% | +1.7% | +2.9% | +0.4% | — |
| Oct 28, 2024 | BMO | 0.35 | 0.35 | +0.0% | 26.62 | +0.9% | +0.8% | -1.9% | -0.5% | +1.1% | +2.2% | — |
| Jul 29, 2024 | BMO | 0.25 | 0.32 | +28.0% | 29.15 | -1.9% | -2.5% | -0.8% | -1.1% | +2.2% | -1.6% | — |
| Apr 29, 2024 | BMO | 0.26 | 0.28 | +7.7% | 25.83 | +0.4% | -0.6% | +0.8% | -0.8% | +1.0% | +0.2% | — |
| Jan 29, 2024 | BMO | 0.41 | 0.44 | +7.3% | 20.82 | -0.1% | -0.5% | -1.4% | +1.0% | -1.9% | -0.1% | — |
| Oct 23, 2023 | BMO | 0.18 | 0.36 | +100.0% | 18.21 | -0.5% | -0.1% | -3.1% | +0.0% | +1.5% | +0.6% | — |
| Jul 24, 2023 | BMO | 0.23 | 0.31 | +34.8% | 20.80 | +0.6% | -0.1% | -2.8% | -1.4% | +1.4% | -0.8% | — |
| Apr 24, 2023 | BMO | 0.19 | 0.24 | +26.3% | 21.72 | -2.7% | -3.5% | -0.4% | +1.4% | -0.3% | -1.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20 | UBS | Upgrade | Neutral → Buy | — | $25.05 | $25.24 | +0.8% | -0.1% | +2.1% | +1.7% | +2.9% | +0.4% |
| Oct 29 | Jefferies | Upgrade | Underperform → Hold | — | $26.62 | $26.87 | +0.9% | +0.8% | -1.9% | -0.5% | +1.1% | +2.2% |
| May 13 | Bernstein | Upgrade | Market Perform → Outperform | — | $26.88 | $27.53 | +2.4% | +0.3% | +0.0% | +1.8% | +0.0% | +1.9% |
| Apr 30 | UBS | Upgrade | Sell → Neutral | — | $25.83 | $25.94 | +0.4% | -0.6% | +0.8% | -0.8% | +1.0% | +0.2% |
| Apr 30 | JP Morgan | Upgrade | Underweight → Neutral | — | $25.83 | $25.94 | +0.4% | -0.6% | +0.8% | -0.8% | +1.0% | +0.2% |
| Jul 25 | Societe Generale | Downgrade | Buy → Hold | — | $22.14 | $20.47 | -7.5% | -7.2% | +3.9% | -0.4% | -1.0% | -1.5% |
| Jan 20 | Jefferies | Downgrade | Buy → Hold | — | $31.54 | $31.03 | -1.6% | -0.8% | -2.0% | -3.0% | +3.2% | -2.9% |
| Jan 14 | HSBC | Upgrade | Hold → Buy | — | $31.51 | $31.57 | +0.2% | +1.0% | -1.9% | +1.0% | -0.8% | -2.0% |
| Jan 12 | Citigroup | Downgrade | Buy → Neutral | — | $35.89 | $30.39 | -15.3% | -14.7% | +2.9% | +1.0% | -1.9% | +1.0% |
| Jul 8 | Deutsche Bank | Downgrade | Buy → Hold | — | $44.01 | $42.88 | -2.6% | -2.5% | -0.1% | +0.7% | -1.0% | +0.3% |
| Mar 18 | JP Morgan | Upgrade | Neutral → Overweight | — | $52.10 | $52.39 | +0.6% | -0.5% | +1.9% | +0.6% | -1.0% | -1.8% |
| Jan 13 | BofA Securities | Maintains | Buy → Buy | — | $44.75 | $44.91 | +0.4% | +0.3% | +1.4% | -0.7% | +0.3% | +0.3% |
| Dec 6 | Morgan Stanley | Upgrade | Equal Weight → Overweight | — | $42.17 | $42.82 | +1.5% | +1.4% | +0.3% | -0.0% | +0.8% | -0.4% |
| Sep 13 | Bernstein | Maintains | Outperform → Outperform | — | $41.18 | $41.59 | +1.0% | +1.2% | -0.5% | -0.7% | +0.2% | +0.1% |
| Oct 16 | Exane BNP Paribas | Downgrade | Outperform → Neutral | — | $37.12 | $36.72 | -1.1% | -0.9% | -0.1% | +1.6% | +0.3% | +0.7% |
| Jun 21 | Natixis | Downgrade | Buy → Neutral | — | $33.67 | $33.55 | -0.4% | -0.9% | -0.8% | +1.1% | -0.3% | -0.3% |
| Dec 12 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $26.97 | $26.88 | -0.3% | +0.4% | +0.0% | -1.1% | -0.1% | -0.6% |
| Oct 26 | HSBC | Upgrade | Hold → Buy | — | $26.88 | $27.33 | +1.7% | +1.4% | -0.9% | +1.4% | -0.5% | -1.0% |
| Aug 10 | UBS | Upgrade | Neutral → Buy | — | $24.78 | $25.31 | +2.1% | +2.3% | +0.4% | -0.3% | +1.2% | +0.2% |
| Mar 21 | Deutsche Bank | Upgrade | Hold → Buy | — | $25.25 | $25.18 | -0.3% | +0.8% | -1.0% | -0.5% | -0.4% | +0.4% |
| Feb 16 | Jefferies | Downgrade | Hold → Underperform | — | $21.48 | $21.92 | +2.0% | +2.2% | +2.0% | -0.3% | +1.3% | +1.4% |
| Jul 28 | Barclays | Upgrade | Underweight → Equal Weight | — | $24.66 | $25.01 | +1.4% | +1.7% | -0.5% | +0.5% | +0.6% | +0.4% |
| Jul 28 | Societe Generale | Upgrade | Hold → Buy | — | $24.66 | $25.01 | +1.4% | +1.7% | -0.5% | +0.5% | +0.6% | +0.4% |
| Jan 27 | Petercam | Downgrade | Buy → Hold | — | $27.50 | $26.29 | -4.4% | -5.3% | -2.4% | +0.7% | -2.2% | +2.0% |
| Oct 21 | UBS | Downgrade | Buy → Neutral | — | $24.84 | $24.55 | -1.2% | +0.1% | -3.9% | +1.3% | +1.1% | +0.3% |
| Sep 29 | Ingalls & Snyder, LLC | Upgrade | Hold → Buy | — | $29.03 | $28.60 | -1.5% | -1.5% | +0.6% | -2.2% | -1.4% | -0.0% |
| Sep 29 | ING | Upgrade | Hold → Buy | — | $29.03 | $28.60 | -1.5% | -1.5% | +0.6% | -2.2% | -1.4% | -0.0% |
| Sep 26 | Morgan Stanley | Upgrade | Equal Weight → Overweight | — | $28.59 | $29.04 | +1.6% | +1.5% | -1.5% | +0.6% | -2.2% | -1.4% |
| Apr 23 | RBC Capital | Downgrade | Outperform → Sector Perform | — | $29.63 | $29.54 | -0.3% | -1.0% | -0.5% | -0.5% | -0.8% | +1.0% |
| Apr 22 | Espirito Santo | Downgrade | Buy → Neutral | — | $31.38 | $29.33 | -6.5% | -5.6% | -1.0% | -0.5% | -0.5% | -0.8% |
| Feb 21 | Exane BNP Paribas | Downgrade | Neutral → Underperform | — | $31.81 | $31.40 | -1.3% | -1.0% | +0.5% | -0.2% | -0.8% | +0.8% |
| Feb 5 | Ingalls & Snyder, LLC | Downgrade | Buy → Hold | — | $31.40 | $30.96 | -1.4% | -1.7% | +2.8% | +1.2% | -0.7% | +1.6% |
| Feb 5 | ING | Downgrade | Buy → Hold | — | $31.40 | $30.96 | -1.4% | -1.7% | +2.8% | +1.2% | -0.7% | +1.6% |
| Oct 28 | Kepler Cheuvreux | Downgrade | Buy → Hold | — | $32.27 | $31.84 | -1.3% | -1.5% | +0.9% | +0.3% | -0.2% | -0.7% |
| Oct 21 | WGZ Bank | Upgrade | Hold → Buy | — | $30.44 | $32.07 | +5.4% | +4.8% | +1.3% | -0.1% | +0.2% | -0.3% |
| Jul 23 | LBBW Research | Upgrade | Sell → Hold | — | $28.51 | $28.49 | -0.1% | -1.2% | +3.7% | +0.9% | -0.8% | -0.8% |
| Jul 23 | JP Morgan | Upgrade | Neutral → Overweight | — | $28.51 | $28.49 | -0.1% | -1.2% | +3.7% | +0.9% | -0.8% | -0.8% |
| Jun 6 | Barclays | Upgrade | Equal Weight → Overweight | — | $25.40 | $25.93 | +2.1% | +2.0% | -0.2% | +0.3% | -1.5% | +0.0% |
| Feb 19 | Societe Generale | Downgrade | Buy → Hold | — | $26.63 | $26.51 | -0.5% | +0.3% | -2.5% | -1.9% | +2.2% | -2.9% |
| Jan 23 | UBS | Upgrade | Neutral → Buy | — | $26.22 | $26.10 | -0.5% | +1.7% | +0.0% | +0.9% | -1.3% | +3.5% |
| Jan 9 | BofA Securities | Maintains | Neutral → Hold | — | $24.28 | $24.09 | -0.8% | +0.6% | +4.0% | -0.6% | +0.1% | +0.2% |
| May 31 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $16.04 | $16.08 | +0.2% | +0.7% | -2.7% | +0.5% | +0.0% | +5.0% |
| May 30 | Morgan Stanley | Upgrade | Underweight → Equal Weight | — | $16.48 | $16.20 | -1.7% | -2.7% | +0.7% | -2.7% | +0.5% | +0.0% |
No insider trades available.
No recent filings available.
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Mondrian Investment Partners Ltd | 7,797,122 | $214M | Reduced | Mar 2026 |
| 2 | Morgan Stanley | 5,683,760 | $154M | Added | Dec 2025 |
| 3 | Fiduciary Management Inc /wi/ | 4,976,913 | $136M | Reduced | Mar 2026 |
| 4 | Fmr Llc | 2,723,804 | $75M | Added | Mar 2026 |
| 5 | Causeway Capital Management Llc | 2,456,190 | $67M | Added | Mar 2026 |
| 6 | Northern Trust Corp | 2,066,767 | $57M | Added | Mar 2026 |
| 7 | Becker Capital Management Inc | 863,809 | $24M | Reduced | Mar 2026 |
| 8 | Bank Of America Corp /de/ | 700,141 | $19M | Added | Mar 2026 |
| 9 | Marshall Wace, Llp | 638,249 | $17M | Added | Mar 2026 |
| 10 | Millennium Management | 552,176 | $15M | Added | Mar 2026 |
| 11 | Ubs Group Ag | 533,794 | $15M | Added | Mar 2026 |
| 12 | D.e. Shaw & Co | 517,229 | $14M | Added | Mar 2026 |
| 13 | Royal Bank Of Canada | 495,310 | $14M | Added | Mar 2026 |
| 14 | Sei Investments Co | 486,941 | $13M | Added | Mar 2026 |
| 15 | Raymond James Financial Inc | 411,066 | $11M | Added | Mar 2026 |
| 16 | Pathstone Holdings, Llc | 402,977 | $11M | Added | Mar 2026 |
| 17 | Quantinno Capital Management Lp | 392,219 | $11M | Added | Mar 2026 |
| 18 | Wells Fargo & Company/mn | 381,756 | $10M | New | Mar 2026 |
| 19 | Cibc World Market Inc. | 365,602 | $10M | — | Mar 2026 |
| 20 | Russell Investments Group, Ltd. | 338,724 | $9M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$25.78B
Enterprise Value
$29.92B
P/E (TTM)
28.80x
Forward P/E
17.30x
PEG Ratio
-0.11x
P/B
2.35x
P/S
1.45x
P/FCF
28.86x
EV/EBITDA
11.33x
Shares Out
962.5M
Financials (TTM)
Revenue
$17.83B
Net Income
$895.0M
EBITDA
$2.64B
Free Cash Flow
$893.0M
Op Cash Flow
$1.16B
EPS Basic
$0.95
EPS Diluted
$0.93
EPS Forward
$1.55
Gross Margin
45.2%
Op Margin
8.0%
Net Margin
5.0%
Balance Sheet
Total Assets
$26.94B
Total Liab.
$15.96B
Total Equity
$10.99B
Cash
$2.79B
LT Debt
$6.93B
Book Value/Sh
$11.42
Debt/Equity
0.74x
Current Ratio
1.32
Quick Ratio
0.94
Returns & Growth
ROE
—
ROA
—
ROIC
5.3%
Rev Growth YoY
-1.0%
EPS Growth YoY
+226.7%
Price Returns
2W
+3.5%
1M
+0.2%
3M
-17.5%
6M
-6.3%
12M
+14.5%
Technicals
52W High
$32.91
52W Low
$22.06
50d MA
$26.90
200d MA
$27.99
RSI (14)
53.30
ATR (14)
$0.48
Beta
0.96
Avg Volume
1.2M
Dividends
Div Rate
$0.34
Div Yield
1.3%
Frequency
1
Ex-Div Date
May 13, 2026
Analyst Price Targets
Consensus
—
High
—
Low
—
Median
—
Data updated apr 26, 2026 7:33pm
· Source: financialmodelingprep.com